Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
KMDA
IL0010941198
Pharmaceuticals
Sales 2024 * | 573M 151M 12.56B | Sales 2025 * | 706M 185M 15.46B | Capitalization | 1.11B 293M 24.4B |
---|---|---|---|---|---|
Net income 2024 * | 46M 12.08M 1.01B | Net income 2025 * | 84M 22.06M 1.84B | EV / Sales 2024 * | 1.94 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.58 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.25% |
Latest transcript on Kamada Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 09/13/09 |
David Tsur
FOU | Founder | 73 | 13/90/13 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 31/17/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 24/19/24 |
Leon Recanati
BRD | Director/Board Member | 76 | 01/05/01 |
David Tsur
FOU | Founder | 73 | 13/90/13 |
1st Jan change | Capi. | |
---|---|---|
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |